Insight Lifetech Co.,Ltd. stated on March 13 through an investor interaction platform that MEMS sensor technology is one of its core technologies. Currently, this technology is primarily applied in FFR-related products and is focused on the coronary artery field. For specific product plans and development progress, please refer to the company's subsequent periodic reports and relevant announcements.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.